Related Experiment Video
Updated: May 5, 2026

09:47
Facile Preparation of Internally Self-assembled Lipid Particles Stabilized by Carbon Nanotubes
Published on: February 19, 2016
9.2K
Core-shell nanocarriers for cancer therapy. Part I: biologically oriented design rules
Ivana d'Angelo1, Claudia Conte, Agnese Miro
1Second University of Napoli, Di.S.T.A.Bi.F , Caserta , Italy.
Expert Opinion on Drug Delivery
|December 10, 2013
Summary
Nanotechnology offers advanced cancer treatments by overcoming chemotherapy limitations. Core-shell nanocarriers and alternative administration routes show promise for improved cancer therapy.
Area of Science:
- Nanomedicine
- Oncology
- Materials Science
Background:
- Nanotechnology provides advanced therapeutic, imaging, and diagnostic approaches in cancer treatment.
- Core-shell nanocarriers are engineered to overcome biological barriers that limit conventional chemotherapy effectiveness.
Purpose of the Study:
- To summarize nanocarrier design principles based on biological requirements.
- To highlight alternative administration routes for nanocarrier-based cancer therapy.
Main Methods:
- Review of nanocarrier design rules dictated by biological requirements.
- Exploration of non-intravenous administration routes for nanoncologicals.
Main Results:
- Nanocarrier engineering can address limitations of conventional chemotherapy.
- Alternative administration routes offer potential for localized chemotherapy delivery.
Conclusions:
- While intravenous injection is common, alternative routes may revolutionize cancer treatment.
- Further research on nanoconstruct stability and interactions is crucial for clinical translation.
Related Concept Videos
Site-Targeted Drug Delivery Systems: Polymeric Carriers
160
Polymeric carriers enhance targeted drug delivery by increasing efficacy while minimizing off-target effects. These carriers comprise a biodegradable polymeric backbone integrated with functional elements that enable targeting, improve physicochemical properties, and regulate drug release.Targeting MechanismsThe targeting ability of polymeric carriers is mediated by a homing device, which is a molecular recognition component designed to selectively bind to specific tissues or cells. Monoclonal...
160
Targeted Cancer Therapies
7.0K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.0K
Modified-Release Drug Delivery Systems: Site-Targeted
164
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
164
Cancer Therapies
8.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.5K

